. 2014 Dec 29;10(1):156–163. doi: 10.1097/JTO.0000000000000380
Copyright © 2014 by the International Association for the Study of Lung Cancer
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
TABLE 3.
IC50 Values of Reversible EGFR-TKIs and Afatinib
